Quarterly ResultApr 14, 2026, 12:48 PM
Lexaria Bioscience Cash Jumps to $5.13M in Q2 2026
AI Summary
Lexaria Bioscience Corp. reported its financial results for the quarter ended February 28, 2026. The company significantly increased its cash position to $5.13 million, up from $1.80 million at August 31, 2025. This substantial growth in cash, alongside a rise in total current assets to $5.77 million, indicates improved liquidity and a stronger financial position for the company.
Key Highlights
- Cash increased to $5.13 million as of Feb 28, 2026.
- Total Current Assets rose to $5.77 million.
- Total Assets grew to $6.49 million.
- 24,787,446 common shares outstanding as of April 13, 2026.